GSE202434 GSE202438 talazoparib 4 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE202434_GSE202438_talazoparib_4_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE202434_GSE202438_talazoparib_4_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE202434_GSE202438_talazoparib_4_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE202434_GSE202438_talazoparib_4_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

vesicle associated membrane protein 7

Gene

small nucleolar RNA host gene 1

Gene

small nucleolar RNA host gene 5

Gene

ribosomal protein SA 2

Gene

long intergenic non-protein coding RNA 511

Gene

small nucleolar RNA host gene 15

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

NBPF member 26

Gene

HERC2 pseudogene 2

Gene

MAGI2 antisense RNA 3

  • Gene

    vesicle associated membrane protein 7


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    ribosomal protein SA 2


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene



  • Gene

    HERC2 pseudogene 2


  • Gene

    MAGI2 antisense RNA 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.